Braeburn Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Braeburn Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011908
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Braeburn Pharmaceuticals Inc (Braeburn), a subsidiary of Apple Tree Partners is a pharmaceutical company that develops novel and long-acting implantable and injectable treatments.The company’s product pipeline includes Probuphine, CAM2038, BB-0417, BB-0817, BB-1216. Its Probuphine, is a a six-month subdermal buprenorphine implant for the treatment of opioid addiction. Braeburn offers CAM2038, a weekly and monthly subcutaneous injection depot formulation of buprenorphine for the treatment of opioid addiction and pain. The company’s products are used in the treatment of cental nervous disorders including addiction, schizophrenia and pain. It conducts research in the areas of opioid use disorder, chronic pain, schizophrenia and spasticity. Braeburn is headquartered in Princeton, New Jersey, the US.

Braeburn Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Braeburn Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Braeburn Pharma Acquires Risperidone Implant from Endo Pharma 12
Venture Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 14
Braeburn Pharma Raises USD35 Million in Venture Financing 15
Braeburn Pharma Raises USD15 Million in Venture Financing 16
Braeburn Pharma Raises USD30 Million in Venture Financing 17
Braeburn Pharma Raises USD23.8 Million in Venture Financing 18
Braeburn Pharma Raises USD10 Million in Venture Financing 19
Braeburn Pharma Raises USD8.5 Million in Venture Financing 20
Braeburn Pharma Raises USD10 Million in Venture Financing 21
Licensing Agreements 22
Braeburn Pharma Enters into Licensing Agreement with Camurus 22
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 23
Camurus Expands Licensing Agreement with Braeburn Pharma 24
Braeburn Pharma Exercises Option For Licensing Agreement With Titan Pharma For Probuphine 26
Braeburn Pharma Enters into Licensing Agreement with Oncothyreon 28
Titan Pharma Amends Licensing Agreement with Braeburn Pharma for Probuphine 29
Equity Offering 31
Braeburn Pharma Withdrawn IPO 31
Braeburn Pharma to Raise USD40 Million in Private Placement of Shares 33
Titan Pharma Raises USD5 Million in Private Placement of Shares 34
Braeburn Pharmaceuticals Inc – Key Competitors 35
Braeburn Pharmaceuticals Inc – Key Employees 36
Braeburn Pharmaceuticals Inc – Locations And Subsidiaries 37
Head Office 37
Recent Developments 38
Corporate Communications 38
Jun 05, 2017: Braeburn Pharmaceuticals Names Michael M. Derkacz as President and CEO 38
Other Significant Developments 39
May 17, 2016: Braeburn Pharmaceuticals Announces Decision to Continue with North Carolina Manufacturing Facility Plans 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Braeburn Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Braeburn Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
Braeburn Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Braeburn Pharma Acquires Risperidone Implant from Endo Pharma 12
Braeburn Pharma Raises USD22 Million in Venture Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 14
Braeburn Pharma Raises USD35 Million in Venture Financing 15
Braeburn Pharma Raises USD15 Million in Venture Financing 16
Braeburn Pharma Raises USD30 Million in Venture Financing 17
Braeburn Pharma Raises USD23.8 Million in Venture Financing 18
Braeburn Pharma Raises USD10 Million in Venture Financing 19
Braeburn Pharma Raises USD8.5 Million in Venture Financing 20
Braeburn Pharma Raises USD10 Million in Venture Financing 21
Braeburn Pharma Enters into Licensing Agreement with Camurus 22
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 23
Camurus Expands Licensing Agreement with Braeburn Pharma 24
Braeburn Pharma Exercises Option For Licensing Agreement With Titan Pharma For Probuphine 26
Braeburn Pharma Enters into Licensing Agreement with Oncothyreon 28
Titan Pharma Amends Licensing Agreement with Braeburn Pharma for Probuphine 29
Braeburn Pharma Withdrawn IPO 31
Braeburn Pharma to Raise USD40 Million in Private Placement of Shares 33
Titan Pharma Raises USD5 Million in Private Placement of Shares 34
Braeburn Pharmaceuticals Inc, Key Competitors 35
Braeburn Pharmaceuticals Inc, Key Employees 36

★海外企業調査レポート[Braeburn Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kratos Defense & Security Solutions, Inc.:企業のM&A・事業提携・投資動向
    Kratos Defense & Security Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kratos Defense & Security Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Nanion Technologies GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Nanion Technologies GmbH (Nanion) is a biotechnology company that develops new innovations in the field of ion channel research and screening. The company offers products such as port-a-patch, patchliner, syncropatch 96, syncropatch 384pe, npc-chips, vesicle prep pro, ordering information, s …
  • Hensel Phelps Construction Co:企業の戦略的SWOT分析
    Hensel Phelps Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Strabag SE:企業の戦略・SWOT・財務情報
    Strabag SE - Strategy, SWOT and Corporate Finance Report Summary Strabag SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bellco Srl:医療機器:M&Aディール及び事業提携情報
    Summary Bellco Srl (Bellco), a subsidiary of Medtronic plc, is a biotechnology company that offers hemodialysis solutions. The company provides chronic line, acute line and neonatal patient products. Its chronic line products comprise haemodiafiltration therapies and dialysis machines, among others. …
  • Herman Miller Inc (MLHR):企業の財務・戦略的SWOT分析
    Herman Miller Inc (MLHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Koch Enterprises, Inc.:企業の戦略的SWOT分析
    Koch Enterprises, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Raschig GmbH:企業の戦略的SWOT分析
    Raschig GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • General Electric Co (GE):医療機器:M&Aディール及び事業提携情報
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services ranging from aircraft engines, power generation and oil and gas production equipment to medical …
  • Oil & Gas Development Co Ltd (OGDC):企業の財務・戦略的SWOT分析
    Oil & Gas Development Co Ltd (OGDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Evgen Pharma Plc (EVG)-製薬・医療分野:企業M&A・提携分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a drug discovery company that develops medicines to treat cancer and neurological diseases. The company uses sulforadex technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. …
  • Buck Institute for Research on Aging-製薬・医療分野:企業M&A・提携分析
    Summary Buck Institute for Research on Aging (Buck Institute) is a healthcare institute that conducts research and offers educational services. The institute concentrates on understanding the connection between aging and chronic disease. It works to understand how normal aging contributes to the dev …
  • Eyevensys SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eyevensys SAS (Eyevensys) is a clinical stage biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its lead product, EYS-606, is a soluble TNFa receptor plasmid associated with the ETIS device to treat non-infectious intermediate and posterior uveitis(NIU); EYS- …
  • Ben E. Keith Co:企業の戦略的SWOT分析
    Ben E. Keith Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Healthsense Inc-医療機器分野:企業M&A・提携分析
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • OBJ Ltd (OBJ):医療機器:M&Aディール及び事業提携情報
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • Jamba, Inc.:企業の戦略・SWOT・財務情報
    Jamba, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jamba, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆